Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,959 | 93 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $436.44 | 23 | $0 (2022) |
| GENZYME CORPORATION | $292.02 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $206.13 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $201.51 | 14 | $0 (2022) |
| Lundbeck LLC | $122.27 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $112.73 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $85.94 | 4 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $81.13 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $71.25 | 7 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $59.20 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.74 | 4 | PFIZER INC. ($23.81) |
| 2022 | $240.27 | 7 | GENZYME CORPORATION ($135.00) |
| 2021 | $1,643 | 82 | GlaxoSmithKline, LLC. ($418.87) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.18 | General |
| 06/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: BioOncology | ||||||
| 11/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Immunology | ||||||
| 06/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/09/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Cardiology | ||||||
| 06/08/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Respiratory | ||||||
| 06/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: RESPIRATORY | ||||||
| 05/19/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Pulmonology | ||||||
| 12/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 11/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2021 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: PAH | ||||||
| 10/28/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROLOGY | ||||||
| 10/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $75.58 | General |
| Category: Cardiology | ||||||
| 10/21/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 33 | 35 | $3,080 | $2,087 |
| 2021 | 6 | 313 | 360 | $34,595 | $18,698 |
| 2020 | 6 | 197 | 221 | $20,708 | $9,382 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 35 | $3,080 | $2,087 | 67.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 114 | 154 | $13,552 | $8,571 | 63.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 69 | $9,108 | $5,763 | 63.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 72 | 74 | $4,884 | $1,983 | 40.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $1,651 | $969.41 | 58.7% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 25 | 25 | $1,650 | $708.75 | 43.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 25 | 25 | $3,750 | $702.52 | 18.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 80 | $7,040 | $3,739 | 53.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 47 | $6,204 | $3,022 | 48.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 47 | 49 | $3,234 | $1,266 | 39.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 15 | 15 | $2,250 | $495.32 | 22.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 15 | 15 | $990.00 | $493.07 | 49.8% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2020 | 15 | 15 | $990.00 | $366.30 | 37.0% |
About Cynthia Shields, NP
Cynthia Shields, NP is a Acute Care healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1588098057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cynthia Shields, NP has received a total of $1,959 in payments from pharmaceutical and medical device companies, with $75.74 received in 2024. These payments were reported across 93 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,959).
As a Medicare-enrolled provider, Shields has provided services to 543 Medicare beneficiaries, totaling 616 services with total Medicare billing of $30,167. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Fort Myers, FL
- Active Since 09/02/2013
- Last Updated 04/15/2024
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1588098057
Products in Payments
- DUPIXENT (Biological) $373.15
- NUCALA (Biological) $211.02
- TRELEGY ELLIPTA (Drug) $208.51
- VYEPTI (Biological) $122.27
- OFEV (Drug) $106.40
- UPTRAVI (Drug) $92.88
- BREZTRI (Drug) $88.58
- STIOLTO RESPIMAT (Drug) $88.05
- XARELTO (Drug) $71.25
- XOLAIR (Biological) $63.80
- ZEPOSIA (Drug) $53.07
- XYWAV (Drug) $37.63
- GLASSIA (Biological) $31.17
- FASENRA (Biological) $30.82
- Yupelri (Drug) $30.07
- ProAir Digihaler (Drug) $25.59
- TIVDAK (Biological) $23.81
- SUNOSI (Drug) $21.57
- Prolastin-C Liquid (Biological) $20.75
- KEYTRUDA (Biological) $20.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Fort Myers
Teri Westenbarger, Aprn, APRN
Acute Care — Payments: $3,006
Debra Berry, Aprn, APRN
Acute Care — Payments: $2,483
Kelly Rios, Aprn, APRN
Acute Care — Payments: $1,804
Mrs. Jennifer Carter, Aprn, Bc, APRN, BC
Acute Care — Payments: $1,788
Amy Ingle, Aprn, APRN
Acute Care — Payments: $1,751
April Mccann, Aprn, APRN
Acute Care — Payments: $1,681